Livzon Pharmaceutical Group Inc ($1513) - buy or sell? Stock discussion, ideas, forum

Livzon Pharmaceutical Group Inc

Livzon Pharmaceutical Group Inc.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$1513	HKEx Main Board	CNE100001QV5	Code: 1513

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 1513 stock

Share your investment idea or question on Livzon Pharmaceutical Group Inc stock:

Latest twits on Livzon Pharmaceutical Group Inc (1513)

No twits yet. Be the first to post!

Have a question about 1513? Ask and other investors will be eager to help you.

Have an idea about 1513? Share it with other investors.

Livzon Pharmaceutical Group Inc news

31/03/2017 Looking for growth? Don't miss Livzon Pharmaceutical Group Inc with its track record of fast growth

24/03/2017 Livzon Pharmaceutical Group Inc reports 26.0% Net Income growth and 0.84 pp EBITDA Margin growth from 15.7% to 16.5%

31/03/2016 Livzon Pharmaceutical Group Inc demonstrated fast growth in recent years. Will the growth continue?

24/03/2016 Livzon Pharmaceutical Group Inc CAPEX dropped on 28.3% in 2015 while Revenue jumped on 19.4%

Livzon Pharmaceutical Group Inc stock price chart

Livzon Pharmaceutical Group Inc financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	2,718	3,122	3,889
EBITDA	638.1	551.5	649.5
Net income	418.2	359.4	441.7
CAPEX	337.0	348.8	762.3
Debt	344.7	652.9	1,221
Cash	844.5	1,432	1,179

Livzon Pharmaceutical Group Inc news

About Livzon Pharmaceutical Group Inc

Livzon Pharmaceutical Group Inc. develops and manufactures pharmaceutical products, including chemical medicines, bio-chemical medicines, biological engineering medicines, chemical compound crude medicines, antibiotics, micro-ecological preparations, patent Chinese medicines, and diagnosis reagents etc.